Centrally applied somatostatin influences morphology of pituitary FSH cells but not FSH release

Gen Physiol Biophys. 2004 Sep;23(3):375-80.

Abstract

Effects of i.c.v. administered somatostatins on morphology and function of pituitary FSH cells were examined in adult male Wistar rats. The animals were given three 1 microg doses of SRIH-14 or SRIH-28 in 5 microl saline every second day. Controls were given the same volume of saline only. Both SRIH treatments lead to a significant decrease in absolute pituitary weight and volume of FSH cells in comparison with controls. Relative pituitary weight was significantly decreased only after SRIH-28 treatments, while FSH secretion was insignificantly decreased by both SRIH treatments. Our results indicate that i.c.v. applied somatostatins have significant inhibitory effect on absolute pituitary weight and on the volume of FSH cells, without affecting the hormone secretion in male rats.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Size / drug effects*
  • Follicle Stimulating Hormone / metabolism*
  • Injections, Intravenous
  • Male
  • Organ Size / drug effects*
  • Pituitary Gland / drug effects
  • Pituitary Gland / metabolism*
  • Rats
  • Rats, Wistar
  • Somatostatin / administration & dosage*

Substances

  • Somatostatin
  • Follicle Stimulating Hormone